RhumbLine Advisers
HIMS icon

RhumbLine Advisers’s Hims & Hers Health HIMS Stock Holding History

RhumbLine Advisers’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22M Sell
633,778
-10,078
-2% -$271K 0.02% 706
2026
Q1 		$13.4M Buy
643,856
+11,503
+2% +$272K 0.01% 922
2025
Q4 		$20.5M Sell
632,353
-36,942
-6% -$1.58M 0.02% 701
2025
Q3 		$38M Buy
669,295
+4,739
+0.7% +$243K 0.03% 468
2025
Q2 		$33.1M Buy
664,556
+67,225
+11% +$3.04M 0.03% 502
2025
Q1 		$17.7M Buy
597,331
+81,107
+16% +$3.01M 0.02% 749
2024
Q4 		$12.5M Buy
516,224
+249,854
+94% +$6.19M 0.01% 954
2024
Q3 		$4.91M Sell
266,370
-2,050
-0.8% -$36.7K ﹤0.01% 1438
2024
Q2 		$5.42M Buy
268,420
+89,535
+50% +$1.49M 0.01% 1354
2024
Q1 		$2.77M Buy
178,885
+1,896
+1% +$21.4K ﹤0.01% 1743
2023
Q4 		$1.58M Sell
176,989
-7,865
-4% -$58.1K ﹤0.01% 2028
2023
Q3 		$1.16M Sell
184,854
-30,641
-14% -$228K ﹤0.01% 2122
2023
Q2 		$2.03M Buy
215,495
+36,064
+20% +$358K ﹤0.01% 1900
2023
Q1 		$1.78M Buy
179,431
+3,214
+2% +$28.2K ﹤0.01% 1867
2022
Q4 		$1.13M Buy
176,217
+2,855
+2% +$16.3K ﹤0.01% 2065
2022
Q3 		$967K Buy
173,362
+20,161
+13% +$121K ﹤0.01% 2149
2022
Q2 		$694K Buy
+153,201
New +$653K ﹤0.01% 2326

Other funds holding HIMS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

RhumbLine Advisers's HIMS Position: Q2 2026 in Review

RhumbLine Advisers reduced its Hims & Hers Health (HIMS) stake by 1.6% in Q2 2026, selling an estimated $271K and leaving 633,778 shares worth $22M. The position accounts for 0.02% of the portfolio, ranked #706.

RhumbLine Advisers first reported a position in HIMS in Q2 2022 and has held it in 17 quarters since. The position peaked at $38M in Q3 2025. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • RhumbLine Advisers held 633,778 shares of Hims & Hers Health worth $22M as of Q2 2026.
  • RhumbLine Advisers sold 10,078 Hims & Hers Health shares in Q2 2026, an estimated $271K.
  • Hims & Hers Health made up 0.02% of RhumbLine Advisers's portfolio in Q2 2026, its #706 holding.
  • RhumbLine Advisers first reported a position in Hims & Hers Health in Q2 2022 and has held it in 17 quarters since.
  • RhumbLine Advisers's Hims & Hers Health position peaked at $38M in Q3 2025.
  • 506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.